These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9088269)

  • 1. Cellular interactions in prostate cancer.
    Lee C
    Br J Urol; 1997 Mar; 79 Suppl 1():21-7. PubMed ID: 9088269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.
    Joseph IB; Nelson JB; Denmeade SR; Isaacs JT
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2507-11. PubMed ID: 9815654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells.
    Gao J; Arnold JT; Isaacs JT
    Cancer Res; 2001 Jul; 61(13):5038-44. PubMed ID: 11431338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of steroid hormones in prostate cancer.
    Wilding G
    Cancer Surv; 1992; 14():113-30. PubMed ID: 1423327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
    Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT
    Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells.
    Huang HF; Murphy TF; Shu P; Barton AB; Barton BE
    Mol Cancer; 2005 Jan; 4(1):2. PubMed ID: 15647107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth of the androgen-dependent tumor of the prostate: role of androgens and of locally expressed growth modulatory factors.
    Limonta P; Dondi D; Marelli MM; Moretti RM; Negri-Cesi P; Motta M
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):401-5. PubMed ID: 7626487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen receptor in prostate cancer.
    Heinlein CA; Chang C
    Endocr Rev; 2004 Apr; 25(2):276-308. PubMed ID: 15082523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model.
    Bonkhoff H; Remberger K
    Prostate; 1996 Feb; 28(2):98-106. PubMed ID: 8604398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta in benign and malignant prostate.
    Lee C; Sintich SM; Mathews EP; Shah AH; Kundu SD; Perry KT; Cho JS; Ilio KY; Cronauer MV; Janulis L; Sensibar JA
    Prostate; 1999 Jun; 39(4):285-90. PubMed ID: 10344218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide growth factors in the prostate as mediators of stromal epithelial interaction.
    Byrne RL; Leung H; Neal DE
    Br J Urol; 1996 May; 77(5):627-33. PubMed ID: 8689101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of urokinase production by androgens in human prostate cancer cells: effect on tumor growth and metastases in vivo.
    Xing RH; Rabbani SA
    Endocrinology; 1999 Sep; 140(9):4056-64. PubMed ID: 10465276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid receptors in prostate cancer tissues and cells: pathophysiology, problems in methodology, clinical value and controversial questions.
    Pavone-Macaluso M; Carruba G; Castagnetta L
    Arch Esp Urol; 1994 Mar; 47(2):189-201. PubMed ID: 8002681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer.
    Denmeade SR; Lin XS; Isaacs JT
    Prostate; 1996 Apr; 28(4):251-65. PubMed ID: 8602401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
    Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A
    Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of prostatic growth and function by peptide growth factors.
    Culig Z; Hobisch A; Cronauer MV; Radmayr C; Hittmair A; Zhang J; Thurnher M; Bartsch G; Klocker H
    Prostate; 1996 Jun; 28(6):392-405. PubMed ID: 8650077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand-independent activation of the androgen receptor in prostate cancer by growth factors and cytokines.
    Jenster G
    J Pathol; 2000 Jul; 191(3):227-8. PubMed ID: 10878541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer.
    Kasper S; Sheppard PC; Yan Y; Pettigrew N; Borowsky AD; Prins GS; Dodd JG; Duckworth ML; Matusik RJ
    Lab Invest; 1998 Mar; 78(3):319-33. PubMed ID: 9520945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Growth factors and prostatic tumors].
    Cussenot O
    Ann Endocrinol (Paris); 1997; 58(5):370-80. PubMed ID: 9685995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanism on androgen-independent progression of prostate cancer].
    Shimazaki J; Akakura K; Furuya Y; Ito H
    Nihon Rinsho; 1997 May; 55(5):1143-8. PubMed ID: 9155166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.